Pakistan Pharmaceutical Manufacturers’ Association (PPMA) showed its distress on behalf of its members on the poor state of affairs of Drugs Regulatory Agency of Pakistan (DRAP). In a statement, the spokesman of PPMA said that the seriousness of the situation can be gauged by the fact that the DRAP has been ineffective right from the date it came into existence through an ordinance. “Not only the major works, but also the routine ones are not being carried out. Even the minutes of the last meeting of the Drugs Registration Board held on 15th June, 2012 have not been issued. There are over 14,000 pending registration applications, and at this retarded rate will take years to clear. PPMA Members have invested tens of millions of rupees not only as registration fee but also on setting-up of new manufacturing sections”, he added.
